Leading Japanese generics firm, Sawai Pharmaceutical, has purchased the generic pharmaceuticals business of Upsher-Smith from its parent ACOVA for $1.05 billion. Minnesota-based Upsher-Smith is a privately held pharmaceutical company, owned by the Evenstad family through their company, ACOVA. Mark Evenstad is the chief executive officer of Upsher-Smith, and his father, Ken Evenstad is the chairman. Upsher-Smith has a diversified product portfolio of over 30 pharmaceutical products, mainly ora...